Company Description
Abgenix, Inc.. The Group's principal activities are to develop and market fully human monoclonal antibody therapies for cancer inflammation and metaolic diseases. The Group's technology and integrated product development platform enable rapid ...
More
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A
Abgenix
Develops human antibody products from its Xenomouse transgenic mouse technology for treating GVHD, psoriasis, arthritis, and cancer. Based in Fremont, California USA.
www.abgenix.com
Develops human antibody products from its Xenomouse transgenic mouse technology for treating GVHD, psoriasis, arthritis, and cancer. Based in Fremont, California USA.
www.abgenix.com
Breaking News
Forbes.com - October 28, 2009 8:53 AM
BusinessWire - Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other life science sectors, today announced the appointment of Gerardo A. Zapata, Ph. D., as President of its ...
